This came after an X post from Marty Makary, MD, Commissioner of the Food and Drug Administration (FDA), who stated that the agency would take action against any companies marketing what he called illegal copycat drugs. Novo Nordisk itself announced on February 9 that it was suing Hims & Hers for patent infringement for both its compounded pill and its injectable semaglutide
The only interaction of concern is pharmacokinetic: the delayed gastric emptying affecting oral hormone absorption
Looking after your mental health Studies in dialysis and pre-dialysis populations consistently report higher rates of anxiety and depression than the general population, with kidney-disease distress affecting a substantial minority of people
They found a total of 544 articles, but once duplicate articles were taken out, only 36 studies remained
Boothwyn itself maintains a "Tell FDA" page on their website, which ironically was created to encourage patients to support compounding pharmacy access to GLP-1 medications